Arcus Biosciences: Q3 Earnings Insights

Arcus Biosciences RCUS reported its Q3 earnings results on Tuesday, November 7, 2023 at 04:00 PM.

Here's what investors need to know about the announcement.

Arcus Biosciences beat estimated earnings by 17.54%, reporting an EPS of $-0.94 versus an estimate of $-1.14.

Revenue was down $1.58 million from the same period last year.

Last quarter the company missed on EPS by $0.04 which was followed by a 1.26% increase in the share price the next day.

Here's a look at Arcus Biosciences's past performance:

Quarter	Q2 2023	Q1 2023	Q4 2022	Q3 2022
EPS Estimate	-1	-1.16	-1.07	-1.04
EPS Actual	-1.04	-1.09	-0.93	-0.90
Revenue Estimate	35.86M	24.97M	23.31M	21.89M
Revenue Actual	29.00M	25.00M	34.00M	33.58M

To track all earnings releases for Arcus Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar